Filters

News Releases

Global Biopharmaceutical Industry pulling out all the stops to address Coronavirus public health crisis

Global Biopharmaceutical Industry pulling out all the stops to address Coronavirus public health crisis

19 March 2020
Pharma industry and patient groups collaborate on a NEW guidance note on best practices for interaction

Pharma industry and patient groups collaborate on a NEW guidance note on best practices for

16 March 2020
Global Health Progress launched to drive cross-sectoral collaborations in support of the Sustainable Development Goals (SDGs)

Global Health Progress launched to drive cross-sectoral collaborations in support of the Sustainable Development Goals

25 October 2019
R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide

R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide

10 January 2019
Unjela Kaleem joins global pharma association as Director of Communications

Unjela Kaleem joins global pharma association as Director of Communications

10 December 2018
R&D biopharmaceutical industry revamp ethical code to apply as base line of industry behavior worldwide

R&D biopharmaceutical industry revamp ethical code to apply as base line of industry behavior worldwide

05 December 2018
David A. Ricks Elected New President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

David A. Ricks Elected New President of the International Federation of Pharmaceutical Manufacturers & Associations

04 December 2018
Pharma industry launches call for coalition of countries to pilot new incentives for antibiotic R&D

Pharma industry launches call for coalition of countries to pilot new incentives for antibiotic R&D

16 November 2018
The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has

13 November 2018
The R&D biopharmaceutical industry supports the Astana Declaration and renewed political commitment towards the importance of primary health care

The R&D biopharmaceutical industry supports the Astana Declaration and renewed political commitment towards the importance

29 October 2018
The R&D-based biopharmaceutical industry welcomes the UN Declaration on NCDs and calls for innovative financing models and multi-sectoral collaboration

The R&D-based biopharmaceutical industry welcomes the UN Declaration on NCDs and calls for innovative financing

27 September 2018
R&D-based biopharmaceutical industry welcomes UN Declaration on TB Partnerships are key to foster innovation and access

R&D-based biopharmaceutical industry welcomes UN Declaration on TB Partnerships are key to foster innovation and

26 September 2018
1 2 3 … 11